Buy the full study
Detailed content of our market study
Inforamtion
- Number of pages : ~ 40 pages
- Format : Digital and PDF versions
- Last update :
Summary and extracts
1 Market Summary
1.1 Definition and presentation
A parapharmacy is a commercial activity that deals with the distribution of "Over the Counter (Otc)" products, non-prescription drugs (Sop) and extra-pharmaceuticals for the purchase of which no prescription is required. The birth of the parapharmacy is recent and dates back to the Bersani Legislative Decree of 2006, which aimed to liberalize the sale of certain pharmaceutical and parapharmaceutical products.
The dividing line between pharmacy and parapharmacy thus refers to the authorization to market pharmaceutical products for which a prescription is required. Instead, what they have in common is that both are required to have a pharmacist present at all times. Parapharmacies are thus a sub-segment of the pharmaceutical industry.
The pharmaceutical segment in Italy does not seem to have been affected by the economic crisis and shows a steady positive evolution, mainly driven by the growth of complementary markets (e.g., organic cosmetics, dermocosmetics, dietary supplements). Pharmacy is still a dominant distribution channel in these markets, to the detriment of parapharmacy in terms of both sales volume and value. However, parapharmacies are the fastest growing distribution channel in 2022.In2022a value of1.126.63 billion dollars, which is expected to reach1.205.81 billion dollarsat the end of2023, with a compound annual growth rate (CAGR) of7,0%.
The pharmacist is perceived as a professional reference figure who gives important advice for patients' health by 65% of Italians. In fact, 75% of people prefer to buy pharmaceutical and extra-pharmaceutical products in a trusted business.
The growth of the parapharmacy market has been supported by a positive trend in the supplement sector.
Although Italians still prefer to purchase drugs and wellness products from a pharmacy or parapharmacy in their area, the pharmaceutical market is moving toward digitization. According to a recent survey conducted by Doxa , 60 percent of consumers would be open to purchasing pharmaceutical products from the pharmacy's website.
1.2 A global market
The global parapharmacy market is booming, driven by a number of factors, including increased health and wellness awareness , an aging population, and the increasing prevalence of online sales channels. Not in all world states, however, the distribution of parapharmaceutical products takes place in places other than pharmacies; for this reason, an ...
1.3 The domestic market
The parapharmaceutical sector consists of an extensive network of private, municipal and rural pharmacies and parapharmacies (***). Multinationalization of the sector has not occurred in Italy as well as abroad, so that more than *** outlets continue to be opened each year. The parapharmacy market has a size of more than *,*** employees; the ...
1.4 Foreign market analysis
In order to find out the value of exports and imports, it is possible to consult data belonging to the generic sector of drug production (***); consequently, these data allow us to analyze the breadth of the market, while also considering other segments not considered in other sections of the study.
As ...
1.5 Impact of the derivative
Demand for extrapharmaceutical products, such as masks and sanitizing gels, has increased production of this type of product. However, in the long run, the various segments of the parapharmaceutical sector did not experience increases, as in the case of OTC products, which experienced a * percent decline. [***]
Impact of Covid-** on demand ...
2 Demand analysis
2.1 Demand characteristics
When analyzing the composition of expenditure and consumption by non-prescription therapeutic category, it can be seen that the drugs with the highest incidence of expenditure are:
medicines for the treatment of cold diseases analgesics gastrointestinal drugs
These three categories account for **.* percent of the value market and **.* percent of the volume ...
2.2 Factors influencing demand
The demand for some pharmaceutical and extrapharmaceutical products is strongly influenced by seasonal factors; in general, the consumption of pharmaceutical products is higher during autumn and winter, as low temperatures and unfavorable weather are some of the causes that can contribute to the weakening of the body. However, depending on the ...
2.3 Geographical distribution of demand
To find out the geographic distribution of demand, it is possible to analyze the available Istat data with respect to the monthly household expenditure item for "other medical products," which refer to goods in parapharmacies. Specifically, it can be seen that spending is highest in the Northeast territories, followed by the ...
2.4 New demand trends
By virtue of the European Directive (***) , which allowed EU member states to decide independently on the marketing of drugs within their territorial jurisdiction, online sales of non-prescription drugs, so-called SOPs and OTCs, have been possible in Italy since ****, after obtaining the approval of the Ministry of Health
Since ****, there has been ...
3 Market structure
3.1 Market structure and dynamics
Active businesses
The graph below was constructed based on data found under "other health care services," as there is no specific data regarding the parapharmaceutical sector. Specifically, it can be seen that in **** the sector increased its presence in the country, with a growth rate of **.* percent. In ****, the last available ...
3.2 Value Chain
The supply chain of the parapharmacy market includes several stages:
raw materials and equipment, such as active ingredients, glass, cardboard, rubber and plastics, are supplied to pharmaceutical companies, which process or use them to produce pharmaceuticals and health care products; the pharmaceutical and non-pharmaceutical products are, then, delivered to depositories; these ...
3.3 Distribution channels
Following the enactment of Legislative Decree No. *** Art. * of July *, ****, the possibility of selling certain types of drugs in places other than pharmacies was guaranteed, with the aim of achieving economic and social revitalization; as a result of this, parapharmacies and GDO corners have become entrenched in the sector, becoming decisive ...
3.4 Major manufacturers of parapharmaceutical goods
Manufacturers are in the business of manufacturing, marketing, and distributing personal and health care merchandise. These products can be used for the prevention, treatment or amelioration of minor ailments, but are not as effective as drugs in the treatment of serious conditions.
Manufacturers have to comply with a number of rules ...
4 Supply analysis
4.1 Overview of the offer
The offerings in the parapharmacy market can be summarized as follows:
OTC & SOP: Also called "over the counter" and "non-prescription" are non-prescription drugs that can be sold without a prescription and are not reimbursable. OTCs are distinguished from SOPs by the freedom to advertise directly to the public, either through print ...
4.2 New trends in online offerings
In ****, new trends in digital pharmacy favored by the pandemic have been attested, resulting in increased demand for online shopping. The main trends attested in the online sector are influenced by:
sustainability and health: renewed attention to two crucial issues, such as sustainability and health, are the main trend in the ...
4.3 Prices
Thanks to the data presented by Cergas Bocconi's Drug Observatory, it can be seen that sales of drugs belonging to the OTC and SOP sector, for medicines without advertising and for self-medication drugs have increased at values of **%; according to forecasts, the market for non-prescription drugs will register a gradual growth ...
5 Rules and regulations
5.1 Italian regulations
Birth of parapharmacies
The possibility of selling certain types of medicines outside of pharmacies is provided for by Art. * of Legislative Decree No. *** of July *, **** containing "Urgent provisions for economic and social revitalization, for the containment and rationalization of public spending, as well as interventions in the field of revenue and ...
5.2 Steps to open a parapharmacy
To open a parapharmacy, there are several steps:
Develop a strategy : It is important to analyze the area and existing competitors to develop a coherent strategy in line with the goals, skills and attitude of the future staff; Choosing the location : to choose the location is mainly influenced by factors of ...
5.3
6 Positioning of actors
6.1 Segmentation
- Farmaè
- Medi-Market
- Bennet
- Pulker Farma Parafarmacie
- Weleda
- Talea Group S.P.A.
- E' QUI S.P.A.
- G.S.M. S.r.l.
List of charts presented in this market study
- Valore mercato globale delle farmacie e delle parafarmaci
- Statistiche per tipologia di parafarmaco
- Taux de croissance des suppléments
- Les troubles de la santé les plus fréquents chez les Italiens
- Recherches pour antihistaminique, crème solaire et aspirine sur Google
All our studies are available online in PDF format
Take a look at an example of our research on another market!
Latest news
Weleda aims to rejuvenate its brand and accelerate innovation - 28/02/2023
- The group has stopped production of homeopathic medicines at its Alsace site.
- The French subsidiary cut 126 jobs
- France remains the second-largest market behind Germany, accounting for 20% of group sales
- Weleda relies on a distribution network built around pharmacies, parapharmacies and specialized organic retailers
Weleda discontinues homeopathy production in Huningue - 06/07/2022
- Weleda discontinues the production of homeopathic products at the Huningue site
- 127 of 290 jobs are under threat
- The site is running at 30% of its capacity.
- Production will be discontinued in France and continued in Germany.
- The Group is looking for a buyer, production will cease in 2023
- The Group's turnover in 2021 amounted to EUR 60 million.
- Weleda's turnover has fallen by 36% in four years
Companies quoted in this study
This study contains a complete overview of the companies in the market, with the latest figures and news for each company. :
Choosing this study means :
Access to more than 35 hours of work
Our studies are the result of over 35 hours of research and analysis. Using our studies allows you to devote more time and added value to your projects.
Benefit from 6 years' experience and over 1,500 industry reports already produced
Our expertise enables us to produce comprehensive studies in all sectors, including niche and emerging markets.
Our know-how and methodology enable us to produce reports that offer unique value for money.
Access to several thousand articles and paid-for data
Businesscoot has access to all the paid economic press as well as exclusive databases to carry out its market research (over 30,000 articles and private sources).
To enhance our research, our analysts also use web indicators (semrush, trends, etc.) to identify market trends and company strategies. (Consult our paying sources)
Guaranteed support after your purchase
A team dedicated to after-sales service, to guarantee you a high level of satisfaction. +44 238 097 0676
A digital format designed for our users
Not only do you have access to a PDF, but also to a digital version designed for our customers. This version gives you access to sources, data in Excel format and graphics. The content of the study can therefore be easily retrieved and adapted for your specific needs.
Our offers :
the parapharmacy market | Italy
- What are the figures on the size and growth of the market?
- What is driving the growth of the market and its evolution?
- What is the positioning of companies in the value chain?
- Data from several dozen databases
5 reports pack (-15%) IT Italy
- 5 reports at €75.6 excluding VAT per study to choose from our Italian catalogue for 12 months
- Save 15% on additional studies purchased
- Choose to be refunded any unused credit at the end of the 12-month period (duration of the pack)
See the terms and conditions of the pack and the refund of unused credit.
Our customer references
They have consulted our studies
Discover the opinions (+500)
Malcolm Vincent
Astoria Finance
Gregoire de Castelnau
Stags Participations
Timothé Huignard
PWC
Paul-Alexis Kebabtchieff
BCG
Aymeric Granet
Publicis Consultant
interviews & case studies
All interviews and case studies (45)
